Kristen Harrington-Smith

Kristen Harrington-Smith

Corporate Officer/Principal chez ADC THERAPEUTICS SA
53 ans
Health Technology
Consumer Services

Profil

Kristen Harrington-Smith currently works at ADC Therapeutics SA, as Chief Commercial Officer & Senior Vice President from 2022.
Ms. Harrington-Smith also formerly worked at eFFECTOR Therapeutics, Inc., as Independent Director from 2022 to 2024, ImmunoGen, Inc., as Chief Commercial Officer from 2021 to 2022, and Novartis Pharmaceuticals, as US Commercial Head-Hematology from 2020 to 2021.
Ms. Harrington-Smith received her undergraduate degree from Williams College and Masters Business Admin degree from Kenan-Flagler Business School.

Postes actifs de Kristen Harrington-Smith

SociétésPosteDébut
ADC THERAPEUTICS SA Corporate Officer/Principal 17/11/2022

Anciens postes connus de Kristen Harrington-Smith

SociétésPosteFin
EFFECTOR THERAPEUTICS, INC. Directeur/Membre du Conseil 21/06/2024
IMMUNOGEN, INC. Corporate Officer/Principal 16/11/2022
Corporate Officer/Principal 01/11/2021
Voir l'expérience en détail de Kristen Harrington-Smith

Formation de Kristen Harrington-Smith

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

6

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Kristen Harrington-Smith